Chronic Pain
Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
Acne Awareness Month: Skin health and medical cannabis
Acne is estimated to affect approximately 95% of people aged between 11 and 30 years old and is the eighth most common skin disease worldwide. In the UK specifically, it’s one of the most common skin conditions, with the country in the top 10 globally for diagnoses in adolescents and young people. Our skin contains part of the endocannabinoid system, the complex cell-signalling network responsible for keeping our skin healthy by regulating important bodily processes like inflammation and oil (sebum) production.
7 min read
18.06.2026
Patrick Bawn
Quick reads
Articles
National Cancer Survivor’s Day: How medical cannabis supports patients living with cancer
Living with cancer involves far more than the diagnosis itself, with symptoms like pain, nausea and poor sleep affecting everyday life. For National Cancer Survivors' Day 2026, this guide explores how medical cannabis may support eligible patients in managing cancer-related symptoms as part of a wider, clinician-led care plan.
10 min read
07.06.2026
Patrick Bawn
What 24 cancer patients told us about medical cannabis for symptom relief: findings from Releaf's 2025 UK patient survey
Releaf's 2025 UK Medical Cannabis Patient Survey is the largest survey of active UK medical cannabis patients ever conducted. Of the 1,669 respondents, 24 selected cancer-related as their primary condition category. All 24 reported an improvement in quality of life, 83.3% rated their treatment extremely, very, or moderately effective, 83.3% experienced no side effects, and 95.8% would recommend medical cannabis to others. Here is what these patients told us about managing their symptoms alongside conventional oncology care.
7 min read
03.06.2026
Sam North
114 patients picked up the phone: Inside the first four months of Releaf Protect legal helpline data
In the first four months of 2026, 114 Releaf patients picked up the phone to the Releaf Protect legal helpline. Across employment disputes, criminal procedure questions, and roadside concerns, the data reveals the everyday reality of being a legal medical cannabis patient in a system still catching up with the law.
7 min read
28.05.2026
Sam North
Decoding Cannabis: what the first placebo-controlled cannabis migraine trial means for patients in 2026
The first randomised, placebo-controlled trial of vaporised cannabis for migraine attacks has finally been published. Researchers at UC San Diego compared THC, CBD, a balanced combination, and placebo across 247 treated migraines. The balanced ratio came out clearly ahead, with sustained benefit at 24 and 48 hours and no serious adverse events. We unpack what the trial proves, where it falls short, and how the results sit alongside Releaf's UK patient survey data on medical cannabis for migraine.
8 min read
26.05.2026
Sam North